AbCellera Biologics Inc. announced that at its AGM held on June 13, 2024, the shareholders approved the election of Andrew Lo, Ph.D. as Class I directors of the company to serve for a three-year term expiring at the company?s annual meeting of shareholders in 2027 and until his or her successor has been elected and qualified.